Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells. [electronic resource]
Producer: 20171027Description: 5374-5383 p. digitalISSN:- 1538-7445
- Animals
- Apoptosis
- Breast Neoplasms -- drug therapy
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- therapeutic use
- Cell Proliferation
- Dendritic Cells -- immunology
- Female
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Transgenic
- Ovarian Neoplasms -- drug therapy
- Receptor, ErbB-2 -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Trastuzumab -- therapeutic use
- Tumor Cells, Cultured
- Vaccines, Subunit -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.